The PTEN hamartoma tumour syndrome (PHTS) includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome.
Automated sequence analysis of the promoter region and exons 1 to 9 of the PTEN gene, followed by MLPA analysis of the PTEN gene if no pathogenic mutations are identified.
SAMPLE REQUIREMENTS & REPORTING TIME
- 5-10ml blood in EDTA or DNA
- 8 weeks for mutation screen
- 2 weeks for testing for a known mutation
- 3 working days for prenatal diagnosis, available by prior arrangement. Please contact the laboratory.